You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 10,435,414


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,435,414
Title:Tricyclic PI3K inhibitor compounds and methods of use
Abstract: Described herein are tricyclic compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure: ##STR00001## or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.
Inventor(s): Braun; Marie-Gabrielle (San Francisco, CA), Garland; Keira (South San Francisco, CA), Hanan; Emily (South San Francisco, CA), Purkey; Hans (South San Francisco, CA), Staben; Steven T. (San Francisco, CA), Heald; Robert Andrew (Harlow Essex, GB), Knight; Jamie (Harlow Essex, GB), Macleod; Calum (Harlow Essex, GB), Lu; Aijun (Beijing, CN), Wu; Guosheng (Beijing, CN), Yeap; Siew Kuen (Harlow Essex, GB)
Assignee: Genentech, Inc. (South San Francisco, CA)
Application Number:16/044,862
Patent Claims:1. A method of treating cancer in a patient having a cancer selected from the group consisting of breast cancer, lung cancer, ovarian cancer, endometrial cancer, prostate cancer, and uterine cancer, comprising administering to said patient a therapeutically effective amount of a compound selected from Formula I: ##STR00545## or stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, wherein: the dotted/solid lines represent a single or double bond; X.sup.a is N; X.sup.b is C and X.sup.c is N; or X.sup.c is C and X.sup.b is N; X.sup.d is CR.sup.2; R.sup.1 is selected from Br, Cl, I, C.sub.2-C.sub.20 heterocyclyl, C.sub.1-C.sub.20 heteroaryl, --NR.sup.3R.sup.4, and -OR.sup.5; R.sup.2 is selected from H, F, Cl, C.sub.1-C.sub.6 alkyl, and --O(C.sub.1-C.sub.6 alkyl); R.sup.3 is selected from H, and C.sub.1-C.sub.6 alkyl; R.sup.4 is selected from H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.20 heterocyclyl, and C.sub.1-C.sub.20 heteroaryl; or R.sup.3 and R.sup.4 form a 4-membered, 5-membered or 6-membered heterocyclyl ring; R.sup.5 is selected from C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.20 heterocyclyl, and C.sub.1-C.sub.20 heteroaryl; R.sup.6 is independently selected from H, C.sub.1-C.sub.4 alkyl, and F; or two geminal or vicinal R.sup.6 groups can form a 3, 4, or 5 membered-carbocyclic ring; p is 2, 3, or 4; A is selected from C.sub.6-C.sub.20 aryl, --(C.sub.6-C.sub.20 aryl)-(C.sub.6-C.sub.20 aryl), --(C.sub.6-C.sub.20 aryl)-(C.sub.1-C.sub.20 heteroaryl), --(C.sub.6-C.sub.20 aryl)-(C.sub.2-C.sub.20 heterocyclyl), --(C.sub.1-C.sub.20 heteroaryl)-(C.sub.2-C.sub.20 heterocyclyl), --(C.sub.1-C.sub.20 heteroaryl)-(C.sub.1-C.sub.20 heteroaryl), C.sub.2-C.sub.20 heterocyclyl, and C.sub.1-C.sub.20 heteroaryl; and where alkyl, aryl, heterocyclyl and heteroaryl are optionally substituted with one or more groups independently selected from F, Cl, I, --CN, --CH.sub.3, --CH.sub.2CH.sub.3, --CH(CH.sub.3).sub.2, C(CH.sub.3).sub.3, --CH.sub.2CH(CH.sub.3).sub.2, --CH.sub.2OH, --CH.sub.2OCH.sub.3, --CH.sub.2CH.sub.2OH, --C(CH.sub.3).sub.2OH, --CH(OH)CH(CH.sub.3).sub.2, --C(CH.sub.3).sub.2CH.sub.2OH, --CH.sub.2CH.sub.2SO.sub.2CH.sub.3, --CH.sub.2OP(O)(OH).sub.2, --CHF.sub.2, --CH.sub.2NH.sub.2, --CH.sub.2NHSO.sub.2CH.sub.3, --CH.sub.2NHCH.sub.3, --CH.sub.2N(CH.sub.3).sub.2, --CF.sub.3, --CH.sub.2CF.sub.3, --CH.sub.2CHF.sub.2, CH(CH.sub.3)CN, --C(CH.sub.3).sub.2CN, --CH.sub.2CN, --CO.sub.2H, --COCH.sub.3, --CO.sub.2CH.sub.3, --CO.sub.2C(CH.sub.3).sub.3, --COCH(OH)CH.sub.3, --CONH.sub.2, --CONHCH.sub.3, --CONHCH.sub.2CH.sub.3, --CONHCH(CH.sub.3).sub.2, --CON(CH.sub.3).sub.2, --C(CH.sub.3).sub.2CONH.sub.2, --NH.sub.2, --NHCH.sub.3, --N(CH.sub.3).sub.2, --NHCOCH.sub.3, --N(CH.sub.3)COCH.sub.3, --NHS(O).sub.2CH.sub.3, --N(CH.sub.3)C(CH.sub.3).sub.2CONH.sub.2, --N(CH.sub.3)CH.sub.2CH.sub.2S(O).sub.2CH.sub.3, --NO.sub.2, .dbd.O, --OH, --OCH.sub.3, --OCH.sub.2CH.sub.3, --OCH.sub.2CH.sub.2OCH.sub.3, --OCH.sub.2CH.sub.2OH, --OCH.sub.2CH.sub.2N(CH.sub.3).sub.2, --OP(O)(OH).sub.2, --S(O).sub.2N(CH.sub.3).sub.2, --SCH.sub.3, --S(O).sub.2CH.sub.3, --S(O).sub.3H, cyclopropyl, cyclobutyl, azetidinyl, oxetanyl, cyclopentyl, tetrahydrofuranyl, morpholinyl, piperidyl, piperazinyl, and tetrahydropyranyl.

2. The method of claim 1, wherein the compound is selected from Formulas Ia and Ic: wherein p is 2, or 3.

3. The method of claim 1, wherein the compound is selected from Formula Ig: ##STR00546##

4. The method of claim 3, wherein the compound is selected from Formulas Ih, Ii and Ij: ##STR00547##

5. The method of claim 1, wherein the compound is selected from Formulas Ik, Il and Im: ##STR00548##

6. The method of claim 4, wherein the compound is selected from Formula In, Io and Ip: ##STR00549## wherein Y is O or NW; and R.sup.7 is selected from H, cyclopropyl, cyclobutyl and C.sub.1-C.sub.6 alkyl optionally substituted with F, Cl, --OCH.sub.3, or --OH; or R.sup.3 and R.sup.7 form a 4-membered, 5-membered or 6-membered heterocyclyl ring.

7. The method of claim 6 wherein Y is NH.

8. The method of claim 6 wherein Y is NR.sup.3, and R.sup.3 and R.sup.7 form a pyrrolidinyl ring.

9. The method of claim 6 wherein Y is O.

10. The method of claim 1 wherein R.sup.1 is Br or substituted pyrazolyl.

11. The method of claim 1 wherein R.sup.1 is selected from: ##STR00550## where the wavy line indicates the site of attachment.

12. The method of claim 1 wherein A is substituted benzo[d]oxazolyl or substituted benzothiazolyl.

13. The method of claim 1 wherein A is selected from the structures: ##STR00551## ##STR00552## where the wavy line indicates the site of attachment.

14. The method of claim 1, wherein the compound is selected from the group consisting of: 5-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[d]ox- azol-2-amine; 4-bromo-1-(2-methyloxazolo[4,5-b]pyridin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulene; 1-(1-(2-methylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[c- d]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenz- o[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)propanamide; (S)-2-(41-phenyl-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amin- o)propanamide; (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)propanamide; (S)-2-((1-(pyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4- -yl)amino)propanamide; (S)-2-((1-(pyrimidin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen- -4-yl)amino)propanamide; (S)-2-((1-(5-cyanopyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]a- zulen-4-yl)amino)propanamide; (S)-2-((1-(6-methoxypyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd- ]azulen-4-yl)amino)propanamide; (S)-2-((1-(pyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4- -yl)amino)propanamide; (S)-2-cyclopropyl-2-((1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-8,9-dihydr- o-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(benzo[d][1,3]dioxol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo- [cd]azulen-4-yl)amino)-2-cyclopropylacetamide, (S)-2-cyclopropyl-2-((1-(3-oxoisoindolin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(quinazolin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(quinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(3-cyanophenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-- 4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(quinazolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-aminoquinazolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[c- d]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(2-methoxy-6-methylpyrimidin-4-yl)-8,9-dihydro-7H- -6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(4-methylpyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2-(hydroxymethyl)-6-methylpyrimidin-4-yl)-8,9-di- hydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; 2-(4-(1-(2-aminobenzo oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyra- zol-1-yl)-2-methylpropanamide; (S)-2-cyclopropyl-2-((1-(pyridazin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(4-(hydroxymethyl)piperidin-1-yl)-8,9-dihydro-7H-- 6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2-methoxypyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,- 9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)-8,9-di- hydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide, (S)-2-((1-(5-chloro-6-methoxypyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaz- abenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-8- ,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-([1,2,4]triazolo[1,5-a]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-((1-(1H-indazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azule- n-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(pyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(thiazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(4-(methylsulfonyl)phenyl)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-8,9-dihydro- -7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-((R)-3-(hydroxymethyl)piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)amino)propanamide; (S)-2-((1-(4-(hydroxymethyl)piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-dia- zabenzo[cd]azulen-4-yl)amino)propanamide; (S)-2-cyclopropyl-2-(41-morpholino-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[c- d]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(oxazol-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenz- o[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(3-(difluoromethoxy)phenyl)-8,9-dihydro-7H-6-oxa-- 2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2-fluoro-4-methoxyphenyl)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2,4-difluorophenyl)-8,9-dihydro-7H-6-oxa-2,9a-di- azabenzo[cd]azulen-4-yl)amino)acetamide; (S)-3-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)benzamide; (S)-2-cyclopropyl-2-((1-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-8,9-dihy- dro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)-8,9- -dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-amino-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl)-8,9-dihyd- ro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(4-(difluoromethoxy)phenyl)-8,9-dihydro-7H-6-oxa-- 2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-4-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)picolinamide; 2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo- [cd]azulen-4-yl)-1H-pyrazol-1-yl)ethan-1-ol; 5-(4-(1-methyl-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]a- zulen-1-yl)benzo[d]oxazol-2-amine; 2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo- [cd]azulen-4-yl)-1H-pyrazol-1-yl)-N,2-dimethylpropanamide; (S)-2-cyclopropyl-2-((1-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)-8,9-dihydr- o-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-([1,2,4]triazolo[1,5-a]pyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9- a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)-2-fluorobenzamide; methyl (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)-2-methoxybenzoate; (S)-2-cyclopropyl-2-((1-(2-(methylsulfonyl)pyridin-4-yl)-8,9-dihydro-7H-6- -oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(1,3-dimethyl-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-o- xa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-- yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)oxy)propanamide; (S)-2-cyclopropyl-2-((1-(3-(difluoromethoxy)-4-methoxyphenyl)-8,9-dihydro- -7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)-2-methoxybenzamide; (S)-2-cyclopropyl-2-((1-(pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(1-methyl-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)-8,9- -dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[- d]oxazol-2-yl)methanol; (S)-2-((1-(1H-pyrazolo[3,4-b]pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaz- abenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabe- nzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)amino)-2-cyclopropylacetamide; 5-(4-bromo-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]inden-1-yl)b- enzo[d]oxazol-2-amine; (S)-2-cyclopropyl-2-((1-(2-methoxyquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; 2-((1-(3-cyanopiperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azu- len-4-yl)amino)-2-cyclopropylacetamide, (S)-2-cyclopropyl-2-((1-(5-(methylsulfonyl)pyridin-3-yl)-8,9-dihydro-7H-6- -oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(3H-imidazo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(thieno[2,3-b]pyridin-4-yl)-8,9-dihydro-7H-6-oxa-- 2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(benzo[d]thiazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]- azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl)-8,9-di- hydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(1,4-oxazepan-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azu- len-4-yl)amino)-2-cyclopropylacetamide; (S)-2-(4-(4-(2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa- -2,9a-diazabenzo[cd]azulen-1-yl)-1H-pyrazol-1-yl)-2-methylpropanamide; (S)-2-cyclopropyl-2-((1-(3-hydroxypiperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,- 9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-7H-6- -oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-aminobenzo[d]thiazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabe- nzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-((1-(2-(methylamino)benzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulen-4-yl)amino)propanamide; (S)-1-(1-(2-(methylamino)benzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-d- iazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-aminoquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[c- d]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-4-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)-2-fluorobenzamide; (S)-2-cyclopropyl-2-((1-(3-hydroxyquinolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9- a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-dia- zabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2- ,9a-diazabenzo[cd]azulen-1-yl)picolinamide; 1-(2-aminobenzo[d]oxazol-5-yl)-N-(3,3-difluorocyclobutyl)-8,9-dihydro-7H-- 6-oxa-2,9a-diazabenzo[cd]azulen-4-amine; 5-(4-bromo-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)b- enzo[d]oxazol-2-amine; (S)-1-(2-aminobenzo[d]oxazol-5-yl)-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a-dia- zabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-([1,3]dioxolo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-dia- zabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-8,9-dihydr- o-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(2-chloro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-8,9-dihydro-7H-6-- oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (6-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)quinoxali- n-2-yl)methanol; (S)-1-(1-(1H-benzo[d]imidazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[- cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(1H-benzo[d][1,2,3]triazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-8,9-dihydro-7H-6-o- xa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; 1-(2-aminobenzo[d]oxazol-5-yl)-N-((1r,3r)-3-fluorocyclobutyl)-8,9-dihydro- -7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-amine; 1-(2-aminobenzo[d]oxazol-5-yl)-N-((1s,3s)-3-fluorocyclobutyl)-8,9-dihydro- -7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-amine; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-amino-7-methylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-1-(1-(3H-[1,2,3]triazolo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9- a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-aminobenzo[d]oxazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-((2-(2-aminobenzo[d]oxazol-5-yl)-3,4-dihydro-5-oxa-1,2a-diazaacenap- hthylen-7-yl)amino)-2-cyclopropylacetamide; (S)-2-((1-(2-amino-7-chlorobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(1-(oxetan-3-yl)-1H-pyrazol-4-yl)-8,9-dihydro-7H-- 6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-cyclopropyl-2-((1-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)-8,9-dihydro-- 7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-2-((1-(1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azule- n-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(6-methoxypyridin-3-yl)-1,7,8,9-tetrahydrooxepino- [4,3,2-cd]indazol-4-yl)amino)acetamide; (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)amino)-2-cyclopropylacetamide; (S)-2-cyclopropyl-2-((1-(8-fluoroquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,- 9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide; (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide; (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)propanamide; (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)propanamide, (S)-1-(1-(2-oxo-3,4-dihydro-2H-benzo[4,5] oxazolo[3,2-a]pyrimidin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azu- len-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diaz- abenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(3-chloro-4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-- 2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(6-(1H-pyrazol-4-yl)pyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaz- abenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(2-amino-7-ethylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-d-

iazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-amino-7-ethylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-- diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (5)-1-(1-(5-(1H-1,2,4-triazol-3-yl)pyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9- a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-1-(1-(4-(1,2,4-thiadiazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diaz- abenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-cyclopropyl-2-((1-(pyrazolo[1,5-a]pyrimidin-5-yl)-8,9-dihydro-7H-6-- oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide; (S)-1-(1-(4-(1H-pyrazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo- [cd]azulen-4-yl)pyrrolidine-2-carboxamide; S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabe- nzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-2-cyclopropylacetamide; (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-2-cyclopropylacetamide; (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-3-methoxy-2-methylpropanamide; (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazab- enzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-3-methoxy-2-methylpropanamide; (S)-1-(1-(4-(2-oxoimidazolidin-1-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-dia- zabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide, (S)-2-((1-(2-amino-7-(trifluoromethyl)benzo[d]oxazol-5-yl)-8,9-dihydro-7H- -6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide; (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenz- o[cd]azulen-4-yl)-N-(4-methoxybenzyl)pyrrolidine-2-carboxamide; (S)-1-(1-(3-oxo-2,3-dihydrobenzo[d]isoxazol-6-yl)-8,9-dihydro-7H-6-oxa-2,- 9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide; (S)-2-4(R)-2-(2-aminobenzo[d]oxazol-5-yl)-4-methyl-3,4-dihydro-5-oxa-1,2a- -diazaacenaphthylen-7-yl)amino)-2-cyclopropylacetamide; (5)-1-(1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)pyrrolidine-2-carboxamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)oxy)propanamide; (S)-2-((1-(2-amino-4-fluorobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa- -2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-2-((1-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,1- 0a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, and (S)-2-((1-(2-aminoquinoxalin-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazac- ycloocta[cd]inden-4-yl)oxy)propanamide; or a pharmaceutically acceptable salt thereof.

15. The method of claim 1, wherein the compound is selected from the group consisting of: (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-2-((1-(2-Aminobenzo[d]thiazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)amino)-2-cyclopropylacetamide; (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-3-fluoro-7,8,9,10-tetrahydro-6-oxa-- 2,10a-diazacycloocta[cd]inden-4-yl)pyrrolidine-2-carboxamide, (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-dia- zacycloocta[cd]inden-4-yl)pyrrolidine-2-carboxamide; (R)-2-(((R)-2-(2-aminobenzo[d]oxazol-5-yl)-4-methyl-3,4-dihydro-5-oxa-1,2- a-diazaacenaphthylen-7-yl)oxy)propanamide; (S)-2-4(R)-2-(2-aminobenzo[d]oxazol-5-yl)-4-methyl-3,4-dihydro-5-oxa-1,2a- -diazaacenaphthylen-7-yl)oxy)propanamide; 5-(4-bromo-8,9-dihydrooxepino[4,3,2-cd]indazol-1(7H)-yl)benzo[d]oxazol-2-- amine; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,- 10a-diazacycloocta[cd]inden-4-yl)(methyl)amino)propanamide; (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)(methyl)amino)propanamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)oxy)butanamide; (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)oxy)butanamide; (S)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)oxy)propanamide; (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)oxy)-2-cyclopropylacetamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazaben- zo[cd]azulen-4-yl)oxy)-2-cyclopropylacetamide; (S)-2-((1-(2-amino-4,7-difluorobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6- -oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-4-(1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)morpholine-3-carboxamide, (R)-2-((1-(2-Amino-7-fluorobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)oxy)propanamide, (S)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)(methyl)amino)propanamide, (S)-2-((1-(2-aminothiazolo[5,4-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa-- 2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-aminooxazolo[4,5-b]pyridin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-d- iazabenzo[cd]azulen-4-yl)oxy)propanamide, (R)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,1- 0a-diazacycloocta[cd]inden-4-yl)oxy)butanamide, (S)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,1- 0a-diazacycloocta[cd]inden-4-yl)oxy)butanamide, (S)-2-((1-(3-fluoro-4-(1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-- 6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-amino-4-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)(methyl)amino)propanamide, (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)butanamide, (S)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)butanamide, (S)-2-((1-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)butanamide; (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabe- nzo[cd]azulen-4-yl)oxy)propanamide, (R)-2-((1-(2-aminobenzo[d]thiazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-aminobenzo[d]thiazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-amino-5-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (R)-2-((1-(2-amino-5-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (R)-2-((1-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (R)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(2-amino-7-fluorobenzo[d]thiazol-5-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-amino-7-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (R)-2-((1-(2-amino-7-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (R)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(2-amino-7-fluorobenzo[d]oxazol-5-yl)-'7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)oxy)-2-cyclopropylacetamide, (S)-2-((2-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-3,4-dihydro-5-oxa-1,2a-d- iazaacenaphthylen-7-yl)oxy)-2-cyclopropylacetamide, (R)-2-((2-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-3,4-dihydro-5-oxa-1,2a-d- iazaacenaphthylen-7-yl)oxy)-2-cyclopropylacetamide, (S)-2-((1-(3-aminobenzo[e][1,2,4]triazin-7-yl)-7,8,9,10-tetrahydro-6-oxa-- 2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide, (S)-2-((1-(2-fluoro-4-(1H-1,2,4-triazol-5-yl)phenyl)-7,8,9,10-tetrahydro-- 6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (2R,3S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a- -diazacycloocta[cd]inden-4-yl)-3-fluoropyrrolidine-2-carboxamide; (S)-2-((1-(2,5-difluoro-4-(1H-1,2,4-triazol-5-yl)phenyl)-7,8,9,10-tetrahy- dro-6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)butanamide; (S)-2-((1-(5-(1H-1,2,4-triazol-5-yl)pyridin-2-yl)-7,8,9,10-tetrahydro-6-o- xa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)propanoic acid; (S)-2-(4-(1-(2-aminothiazolo[5,4-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-ox- a-2,10a-diazacycloocta[cd]inden-4-yl)-1H-pyrazol-1-yl)butanamide; (R)-2-(4-(1-(2-aminothiazol o[5,4-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]i- nden-4-yl)-1H-pyrazol-1-yl)butanamide; (2S,3R)-1-(1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10- a-diazacycloocta[cd]inden-4-yl)-3-methoxypyrrolidine-2-carboxamide; (S)-2-(4-(1-(2-aminooxazolo[4,5-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa- -2,10a-diazacycloocta[cd]inden-4-yl)-1H-pyrazol-1-yl)butanamide; (R)-2-(4-(1-(2-aminooxazolo[4,5-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa- -2,10a-diazacycloocta[cd]inden-4-yl)-1H-pyrazol-1-yl)butanamide; (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)-3-methoxypropanamide; (R)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-d- iazacycloocta[cd]inden-4-yl)oxy)-3-methoxypropanamide; (S)-2-cyclopropyl-2-((1-(3-fluoro-4-(1H-1,2,4-triazol-5-yl)phenyl)-7,8,9,- 10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)acetamide; (R)-2-cyclopropyl-2-((1-(3-fluoro-4-(1H-1,2,4-triazol-5-yl)phenyl)-7,8,9,- 10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)acetamide; (S)-2-((1-(5-fluoro-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-7,8,9,10-tetra- hydro-6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)oxy)propanamide; (2S,3S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diaza- benzo[cd]azulen-4-yl)-3-methylpyrrolidine-2-carboxamide; (2S,3S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a- -diazacycloocta[cd]inden-4-yl)-3-methylpyrrolidine-2-carboxamide; (2S,3R)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a- -diazacycloocta[cd]inden-4-yl)-3-methoxypyrrolidine-2-carboxamide; (S)-2-(4-(1-(2-aminooxazolo[4,5-b]pyridin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide; (R)-2-(4-(1-(2-aminooxazolo[4,5-b]pyridin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a- -diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide; (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-di- azacycloocta[cd]inden-4-yl)oxy)butanoic acid; (R)-2-((1-(2-aminothiazolo[5,4-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa-- 2,10a-diazacycloocta[cd]inden-4-yl)oxy)-3-methoxypropanamide; and (S)-2-((1-(2-aminothiazolo[5,4-b]pyridin-5-yl)-7,8,9,10-tetrahydro-6-oxa-- 2,10a-diazacycloocta[cd]inden-4-yl)oxy)-3-methoxypropanamide; or a pharmaceutically acceptable salt thereof.

16. The method of claim 1 further comprising administering to the patient a therapeutic agent selected from 5-FU, docetaxel, eribulin, gemcitabine, cobimetinib, ipatasertib, paclitaxel, tamoxifen, fulvestrant, GDC-0810, dexamethasone, palbociclib, bevacizumab, pertuzumab, trastuzumab emtansine, trastuzumab and letrozole.

17. The method of claim 1 wherein the cancer is breast cancer.

18. The method of claim 17 wherein the breast cancer is estrogen receptor positive (ER+) breast cancer.

19. The method of claim 1 wherein the breast cancer subtype is Basal or Luminal.

20. The method of claim 1 wherein the cancer expresses a PIK3CA mutant selected from E542K, E545K, Q546R, H1047L and H1047R.

21. The method of claim 1 wherein the cancer expresses a PTEN mutant.

22. The method of claim 1 wherein the cancer is hormone receptor positive (HR+).

23. The method of claim 1 wherein the patient is HER2 negative, ER (estrogen receptor) negative, and PR (progesterone receptor) negative.

Details for Patent 10,435,414

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 09/25/1998 ⤷  Try a Trial 2035-09-08
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 02/10/2017 ⤷  Try a Trial 2035-09-08
Genentech, Inc. AVASTIN bevacizumab Injection 125085 02/26/2004 ⤷  Try a Trial 2035-09-08
Genentech, Inc. PERJETA pertuzumab Injection 125409 06/08/2012 ⤷  Try a Trial 2035-09-08
Genentech, Inc. HERCEPTIN HYLECTA trastuzumab and hyaluronidase-oysk Injection 761106 02/28/2019 ⤷  Try a Trial 2035-09-08
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.